Literature DB >> 6608107

Thymic T cells are driven to expand upon interaction with self-class II major histocompatibility complex gene products on accessory cells.

K L Rock, B Benacerraf.   

Abstract

Murine thymocytes induce the monokine interleukin 1 upon in vitro coculture with a radioresistant Ia-bearing accessory cell [murine Ia molecule is a class II major histocompatibility complex (MHC) antigen]. The generation of interleukin 1 is critically dependent on the function of I-region gene products on accessory cells. The induced interleukin 1 appears to allow the activation and proliferation of self-MHC-specific thymocytes. Thus, in the absence of added exogenous factors, there is an Ia-dependent thymocyte proliferation. This selective activation of thymocytes is observed with both mature and immature thymic T cells. This in vitro response results in the selective amplification of developing T cells with self-MHC specificity and could be of importance to the in vivo commitment of T cells to MHC determinants that occurs in the thymus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608107      PMCID: PMC344798          DOI: 10.1073/pnas.81.4.1221

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  The somatic generation of immune recognition.

Authors:  N K Jerne
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

Review 2.  Current concepts of the immunological function of the thymus.

Authors:  J F Miller; D Osoba
Journal:  Physiol Rev       Date:  1967-07       Impact factor: 37.312

Review 3.  MHC-restricted T cell activation: analysis with T cell hybridomas.

Authors:  K L Rock; B Benacerraf
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

4.  Inhibition of interleukin synthesis and T cell proliferation by a monoclonal anti-Ia antibody.

Authors:  S C Gilman; J S Rosenberg; J D Feldman
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

5.  The role of Ia molecules in the activation of T lymphocytes. II. Ia-restricted recognition of allo K/D antigens is required for class I MHC-stimulated mixed lymphocyte responses.

Authors:  K L Rock; M C Barnes; R N Germain; B Benacerraf
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

6.  A monoclonal antibody discriminating between subsets of T and B cells.

Authors:  J Bruce; F W Symington; T J McKearn; J Sprent
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

7.  The role of Ia molecules in the activation of T lymphocytes. I. The activation of an IL 1-dependent IL 2-producing T cell hybridoma by Con A requires an interaction, which is not H-2-restricted, with an Ia-bearing accessory cell.

Authors:  K L Rock
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  The role of Ia molecules in the activation of T lymphocytes. III. Antigen-specific, Ia-restricted, interleukin 2-producing T cell hybridomas with detectable affinity for the restricting I-A molecule.

Authors:  K L Rock; B Benacerraf
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

9.  Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cells but not K/D-restricted T cells.

Authors:  A M Kruisbeek; M J Fultz; S O Sharrow; A Singer; J J Mond
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

10.  Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation.

Authors:  K L Rock; B Benacerraf
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more
  10 in total

1.  Mechanism of MHC class II restriction in the interaction between specific suppressor and responder T cells in a proliferative response: Ia interaction with a putative anti-self receptor, expressed on pre-activated responder cells.

Authors:  M B Zaitseva; B D Brondz
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

Review 2.  Acquisition of MHC-restriction specificities: role of thymic stromal cells.

Authors:  A M Kruisbeek; D L Longo
Journal:  Surv Immunol Res       Date:  1985

3.  In vitro effects of gold sodium thiomalate on IL-1, IL-2 production, IL-2 receptor expression and IL-2 responsiveness in thymocytes and peripheral blood mononuclear cells.

Authors:  E Blitstein-Willinger; A Streller
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

4.  Gene encoding T-cell-activating protein TAP maps to the Ly-6 locus.

Authors:  H Reiser; E T Yeh; C F Gramm; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Reversal of ageing changes in the thymus of rats by chemical or surgical castration.

Authors:  M D Kendall; F T Fitzpatrick; B D Greenstein; F Khoylou; B Safieh; A Hamblin
Journal:  Cell Tissue Res       Date:  1990-09       Impact factor: 5.249

6.  Monoclonal antibodies against human Ia antigens stimulate monocytes to secrete interleukin 1.

Authors:  R Palacios
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  Analysis of thymocyte MHC specificity with thymocyte hybridomas.

Authors:  E T Yeh; B Benacerraf; K L Rock
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

Review 8.  Cell-mediated immunity in virus infections of the central nervous system.

Authors:  P C Doherty
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

9.  TAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytes.

Authors:  K L Rock; E T Yeh; C F Gramm; S I Haber; H Reiser; B Benacerraf
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

10.  Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.

Authors:  A M Kruisbeek; J J Mond; B J Fowlkes; J A Carmen; S Bridges; D L Longo
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.